Will Lewis, Insmed CEO, joins ‘Fast Money’ to discuss the company’s lung drug being greenlit by the FDA and what it means for for the stock.
05:06
3 hours ago
Trending
- The ‘Fast Money’ traders debate Treasury Sec. Bessent’s call to lower Fed rates impact on the markets
- Crypto exchange Bullish surges in public debut: CNBC Crypto World
- What’s next for rates as investors digest inflation data
- Asia stock markets today: live updates
- Despite CPI, economists agree higher prices are coming
- Cisco Systems deserves more respect in AI, and its quarterly results prove it
- Insmed CEO on what’s next for company after FDA greenlights lung disease drug
- What’s likely to move the market in the next trading session
Insmed CEO on what’s next for company after FDA greenlights lung disease drug
